Ligand Pharmaceuticals
LGND
#2821
Rank
C$8.27 B
Marketcap
C$413.50
Share price
-3.24%
Change (1 day)
42.80%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2026 (TTM): C$3.58

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$3.71. In 2025 the company made an earnings per share (EPS) of C$9.01 an increase over its 2024 EPS that were of C-$0.07153.

EPS history for Ligand Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$3.58-60.29%
2025C$9.01-12700%
2024C-$0.07153-101.73%
2023C$4.13-245.96%
2022C-$2.83-157.23%
2021C$4.95-2571.43%
2020C-$0.20-100.46%
2019C$43.79353.48%
2018C$9.661025%
2017C$0.86-700%
2016C-$0.14-100.87%
2015C$16.541859.32%
2014C$0.845.36%
2013C$0.808.0704505322479E+18%
2012C$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.56 157.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-72.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.19 1,092.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$24.86 571.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.02-154.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-61.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47 74.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.12 11.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
C-$0.52-113.90%๐Ÿ‡บ๐Ÿ‡ธ USA